Effect of durvalumab on local control after concurrent chemoradiotherapy for locally advanced non‐small cell lung cancer in comparison with chemoradiotherapy alone

BACKGROUND: Durvalumab after concurrent chemoradiotherapy (CCRT) for locally advanced non‐small cell lung cancer (LA‐NSCLC) has been found to significantly improve overall survival (OS). However, the effect of durvalumab on local control remains unclear. Here, we evaluated the effect of the durvalum...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Thorac Cancer
Autores principales: Abe, Takanori, Saito, Satoshi, Iino, Misaki, Aoshika, Tomomi, Ryuno, Yasuhiro, Ohta, Tomohiro, Igari, Mitsunobu, Hirai, Ryuta, Kumazaki, Yu, Miura, Yu, Kaira, Kyoichi, Kagamu, Hiroshi, Noda, Shin‐ei, Kato, Shingo
Formato: Artigo
Lenguaje:Inglês
Publicado: John Wiley & Sons Australia, Ltd 2020
Materias:
Original Articles
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7812072/
https://ncbi.nlm.nih.gov/pubmed/33289347
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1759-7714.13764
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares